Kolexia
Dayen Charles Pneumologie
Dayen Charles
Pneumologie
Ch Saint-quentin
Saint-Quentin, France
125 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du poumon Carcinome pulmonaire à petites cellules Carcinome pulmonaire non à petites cellules Carcinomes Adénocarcinome Carcinome épidermoïde Broncho-pneumopathie chronique obstructive Tumeurs du médiastin Néphrocarcinome

Collaborateurs

Voir plus
Douadi Youcef
Douadi Youcef
Ch Saint-quentin, Saint-Quentin, France
Carre Olivier
Carre Olivier
Centre Hospitalier de Doullens, Doullens, France
Suguenot Remi
Suguenot Remi
Ch Saint-quentin, Saint-Quentin, France
Lecuyer Emmanuelle
Lecuyer Emmanuelle
Ch Saint-quentin, Saint-Quentin, France

Industries

Voir plus
AstraZeneca
32 collaboration(s)
Dernière en 2023
A+A
24 collaboration(s)
Dernière en 2023
GSK
24 collaboration(s)
Dernière en 2023
Sanofi
20 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Study of Safety and Efficacy of Brigatinib Plus Chemotherapy or Brigatinib Only in Advanced ALK-Positive Lung Cancer (MASTERPROTOCOL ALK): A Phase II Randomized, Open-Labelled, Multicenter Study of Safety & Efficacy of Combination Brigatinib and Carboplatin-Pemetrexed Therapy or Brigatinib Monotherapy as First-Line Treatment in Advanced ALK-Positive Non-Small Cell Lung Cancer
Essai Clinique (Intergroupe Francophone de Cancérologie Thoracique)   06 mars 2024
Collaboration Ville–Hôpital innovante
28e Congrès de Pneumologie de Langue Française   01 janvier 2024
TAXIO: A Phase II Study Assessing the Efficacy of Etoposide Free Chemotherapy Plus Durvalumab (MEDI4736) in First Line Extensive Disease Small Cell Lung Cancer (SCLC)
Essai Clinique (Intergroupe Francophone de Cancérologie Thoracique)   18 décembre 2023
Endocavitary Right Ventricular Cardiac Metastasis of a Lung Adenocarcinoma Treated by Surgery: A Case Report About a Novel Multimodal Therapeutic Approach.
Case reports in oncology   14 novembre 2023
2026P Small cell lung cancer (SCLC) in the KBP-2020-CPHG cohort and comparison with 2000 and 2010
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
Long-term effectiveness and treatment sequences in patients with extensive stage small cell lung cancer receiving atezolizumab plus chemotherapy: Results of the IFCT-1905 CLINATEZO real-world study.
Lung cancer (Amsterdam, Netherlands)   22 septembre 2023
Endoscopic resection of tracheal and bronchial granular cell tumours: A national multicentre retrospective study.
Respirology (Carlton, Vic.)   10 juin 2023
A Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR and Anti-c-MET Bispecific Antibody, in Patients With Advanced NSCLC and Other Solid Tumors: Phase 1/2 Dose Escalation and Expansion Study Evaluating MCLA-129, a Human Anti-EGFR and Anti-c-MET Bispecific Antibody, in Patients With Advanced NSCLC and Other Solid Tumors
Essai Clinique (Merus N.V.)   07 mai 2023
Ibe2i-TIPCI: Identification of Predictive Biomarkers for Immune-Related Adverse Events (irAEs) in Patients
Essai Clinique (CHU Amiens-Picardie)   25 avril 2023
Ultimate: Phase III Study Comparing the Efficacy of Paclitaxel-bevacizumab With Docetaxel in 2nd or 3rd Line of Treatment of Non Squamous Non Small Cells Lung Cancer
Essai Clinique (Intergroupe Francophone de Cancérologie Thoracique)   10 mars 2023